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Abstract
Background—High-level disinfectants (HLDs) are used throughout the healthcare industry to 
chemically disinfect reusable, semicritical medical and dental devices to control and prevent 
healthcare-associated infections among patient populations. Workers who use HLDs are at risk of 
exposure to these chemicals, some of which are respiratory and skin irritants and sensitizers.
Objective—To evaluate exposure controls used and to better understand impediments to 
healthcare workers using personal protective equipment while handling HLDs.
Design—Web-based survey.
Participants—A targeted sample of members of professional practice organizations representing 
nurses, technologists/technicians, dental professionals, respiratory therapists, and others who 
reported handling HLDs in the previous 7 calendar days. Participating organizations invited either 
all or a random sample of members via email, which included a hyperlink to the survey.
Methods—Descriptive analyses were conducted including simple frequencies and prevalences.
Results—A total of 4,657 respondents completed the survey. The HLDs used most often were 
glutaraldehyde (59%), peracetic acid (16%), and ortho-phthalaldehyde (15%). Examples of work 
practices or events that could increase exposure risk included failure to wear water-resistant gowns 
(44%); absence of standard procedures for minimizing exposure (19%); lack of safe handling 
training (17%); failure to wear protective gloves (9%); and a spill/leak of HLD during handling 
(5%). Among all respondents, 12% reported skin contact with HLDs, and 33% of these 
respondents reported that they did not always wear gloves.
Conclusion—Findings indicated that precautionary practices were not always used, 
underscoring the importance of improved employer and worker training and education regarding 
HLD hazards.
High-level disinfectants (HLDs) are used throughout the healthcare industry to chemically 
disinfect reusable, semicritical medical and dental devices. Currently, the Food and Drug 
Administration (FDA)-approved HLDs in commercially available products contain one of 
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the following active ingredients: glutaraldehyde, orthophthalaldehyde (OPA), peracetic acid 
(PA), hydrogen peroxide (HP), hydrogen peroxide/peracetic acid (HPPA), or hypochlorous 
acid/hypochlorite (bleach).1
Glutaraldehyde has been linked to adverse occupational health effects including 
dermatitis2–6 and asthma.7–9 It is important to note that little is known about the potential 
occupational health risks of other HLDs more recently cleared by the FDA. A case report in 
Japan suggests that occupational asthma and dermatitis were caused by OPA exposure in a 
nurse working in an endoscopy unit.10 Also, HPPA has been implicated in 2 cases of 
occupational asthma.11
Workplace controls for reducing exposure during the use of HLDs in the disinfection 
processes in U.S. healthcare settings have not been previously reported in the literature. A 
2007 report on a study of 5 hospitals in Quebec indicated that all 19 locations that used 
glutaraldehyde lacked any type of local exhaust ventilation (LEV), with half of the 53 
workers reporting at least 1 incident of dermal exposure.12 Guidelines for the safe use and 
handling of glutaraldehyde, including recommended engineering controls, personal 
protective equipment (PPE), and work practices, have been published by the National 
Institute for Occupational Safety and Health (NIOSH)13 and the Occupational Safety and 
Health Administration (OSHA).14
The primary objective of this study was to describe the current usage, precautionary 
practices including extent of exposure control use, and barriers to using PPE by healthcare 
workers who disinfect medical devices using HLDs. This study is distinct from previous 
studies; it has national reach, includes commonly used HLDs in healthcare, and includes a 
large number of respondents and diverse occupations and workplaces.
Methods
Survey Methodology
The NIOSH Health and Safety Practices Survey of Healthcare Workers was a voluntary, 
anonymous, multimodule, web-based survey conducted in early 2011. The study population 
for the hazard module on HLDs included members of professional practice organizations 
representing nurses, technologists/technicians, dental professionals, respiratory therapists, 
and others who reported handling 1 or more HLDs in the previous week. Participating 
organizations invited members via an e-mail that included a hyperlink to the survey.
Information on the methods used in the development and testing of the survey web 
instrument, survey implementation, respondent characteristics, strengths and limitations, and 
other information have been previously reported.15
Hazard Module on HLDs
The multimodule survey included 1 screening module, 7 hazard modules addressing selected 
chemical hazards commonly found in healthcare settings, and 1 core module. Participants 
were eligible to complete the hazard module on HLDs if they responded ‘yes’ to the 
screening question asking whether they had chemically disinfected medical or dental devices 
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using 1 or more of the following HLDs during the previous week: glutaraldehyde, OPA, PA, 
HP, and HPPA. The format of the questions varied and included multiple choice, multipart, 
and yes/no questions. Most questions sought information relative to the previous 7 calendar 
days unless otherwise noted. To minimize response error, photos were included for 
automated reprocessors, manual immersion trays, LEV, and respirators.
Data Analysis
Data were analyzed using SAS 9.3.16 Simple frequencies and prevalences are presented. 
Stratification was used to further describe some aspects of the use of HLDs. Results include 
responses to questions in the HLD hazard module and selected questions in the core module 
that describe demographic, employer, and occupation characteristics. Respondents who 
worked outside the United States and its territories were excluded from analyses.
Human Subjects Review Board
The NIOSH Institutional Review Board determined that the activities in this project 
constituted surveillance and did not meet the criteria of research according to 45 CFR 
46.1101(b) (2) and Centers for Disease Control and Prevention's Guidelines for Defining 
Public Health Research and Public Health Non-Research.17
Results
Respondent Characteristics
A total of 4,657 respondents completed the hazard module addressing HLDs. Of these, 
3,994 (86%) completed the core module and thus could be characterized by demographic 
and other descriptive information. Respondents were mostly female (80%), non-Hispanic 
(96%), and older than 40 years of age (83%). The majority of respondents were white 
(91%); few reported that they were black (5%), Asian (4%), or another race (2%). Education 
level varied, with most having either an Associate's degree (32%) or a Bachelor's degree 
(31%), followed by Master's degree (12%), vocational certificate (12%), professional/
doctoral degree (9%), and less than grade 12 (5%).
Respondents included mainly nurses (41%), technologists/technicians (23%), dentists/dental 
professionals (20%), and respiratory therapists (13%) (Table 1). Of the respondents, 80% 
had ≥6 years of experience in their current occupation, and 52% reported working with their 
current employer for ≤10 years. In addition, 56% reported using HLDs for ≥11 years; 455 of 
3,896 respondents (12%) were members of a labor union. The majority of respondents 
indicated that they were employed at hospitals (62%), with most others working in dentist 
offices (17%) or outpatient care facilities (11%). In addition, 50% reported that their 
employer had ≥250 employees. The percentages of for-profit and non-profit employers were 
similar, 44% and 43% respectively, with the remaining employers being publicly owned 
institutions. Respondents worked in all U.S. geographical regions, with the South having the 
highest representation (33%), followed by the Midwest (27%), the West (21%), and the 
Northeast (20%). More than 50% of employers were located in large cities.
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When asked to select from a list the HLD used most often during the previous week, 59% of 
respondents reported glutaraldehyde, followed by PA (16%), OPA (15%), HP (8%), HPPA 
(2%), and other (0.2%) (Table 2). Because dental professionals represented 1 of every 5 
respondents, the high glutaraldehyde use among this group (92%) greatly contributed to the 
reported use by all respondents, which was 52% when dental professionals were excluded. 
The number of days disinfecting with HLDs over the previous 7 days differed; 35% reported 
1 day only and comprised the largest response group. When respondents were asked to 
report the total time they spent handling or working with HLDs during the previous week, 
they were instructed to include only the time spent loading or unloading instruments, adding 
and/or replacing HLD solution, and cleaning reprocessors or immersion trays. Of the 
respondents, 63% reported that they had handled or worked with HLDs for a total of ≤1 hour 
during the previous week, and 90% of respondents used them for ≤5 hours. Most 
respondents (3,312 of 4,366 or 76%) reported that the total time spent handling HLDs 
during the previous week was no different than usual. Most respondents (71%) reported that 
they had disinfected ≤10 instruments during the previous week, and <10% reported 
disinfecting >50 instruments. In addition, 64% of respondents reported using manual 
immersion disinfection systems; 48% reported using automated systems (ie, reprocessors); 
and 12% reported using both systems.
Training and Awareness of Employer Procedures
Of 4,572 respondents, 766 (17%) reported that they had never been trained on the safe 
handling of HLDs. Of the 3,806 who had received training, 42% reported that the training 
had been >12 months previously. Of 4,566 respondents, 872 (19%) reported that their 
employer lacked standard procedures for safe handling of HLDs or were unaware of their 
existence.
Presence of LEV on Manual and Automated Disinfection Systems
Only 24% of respondents reported that manual disinfection systems were equipped with 
LEV, while 47% reported LEV on automated systems. A substantial percentage of 
respondents using manual disinfection systems (34%) and automated disinfection systems 
(38%) did not know whether LEV was present. For systems with LEV present, 97% of 
respondents perceived the LEV to be effective. For systems lacking LEV, 1 of every 5 
respondents reported that the general ventilation was ineffective.
Adding or Removing HLDs from Disinfection Systems
Of 4,125 respondents, 1,227 (30%) reported manually pouring HLDs into automated 
reprocessing units or manual immersion trays in the previous 7 days. Of the respondents that 
reported manual pouring, 47% reported pouring <1 gallon, and only 5% reported pouring 
>10 gallons. Of 4,105 respondents, 917 (22%) reported that they had manually drained 
HLDs from automated processing units or immersion trays during the same period.
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Of 4,111 respondents, 482 (12%) reported that their skin had come into direct contact with 
HLDs during the previous week.
Use of Personal Protective Equipment
The proportion of respondents reporting that they did not always wear a water-resistant 
gown/outer garment when handling HLDs was 44%; for or eye/face protection, that 
proportion was 42%. Only 9% of respondents reported that they did not always wear 
protective gloves. Moreover, for those respondents who reported skin contact with HLDs, 
the proportion that did not always wear protective gloves was 33%. Few respondents 
reported using a respirator.
Respondents who reported that they did not always wear PPE when handling HLDs were 
asked to select all that applied from a list of 9 reasons for not wearing PPE; percentages of 
respondents selecting each of these reasons by type of PPE are presented in Table 3. 
‘Exposure was minimal’ and ‘not part of our protocol’ were the top two reasons reported by 
respondents for not always wearing gloves, gowns/outer garments, or eye/face protection.
Respondents were 3, 2, and 1.5 times more likely to report never wearing gloves, eye/face 
protection, and water-resistant gowns, respectively, if they had never received training on the 
safe handling of HLDs.
Frequency of Spills and Availability of Spill Kits
Respondents were asked whether spills occurred in the previous 7 days while they were 
handling HLDs and, if so, whether the spills were <2 cups (∼500 ml) or ≥2 cups. Of 4,050 
respondents, 173 (4%) reported spills of <2 cups, and 34 of 3,915 (<1%) reported spills of 
≥2 cups. Only 151 of 182 of those reporting spills (83%) indicated that these spills were 
always cleaned up. Of 4,110 respondents, 2,917 (71%) reported that hazardous chemical 
spill kits were available, while 29% indicated that they were not available or did not know 
whether they were available.
Took Home Potentially Contaminated Clothing
When respondents were asked whether they took home any clothing that came into contact 
with HLDs, 560 (14%) responded affirmatively and another 7% did not know.
Exposure Monitoring
When respondents were asked whether exposure monitoring had been conducted in the 
previous 12 months to assess their own or their coworkers' exposure to HLDs, 548 of 3,899 
(14%) reported that monitoring had been conducted. Most of these respondents (64%) 
reported that the monitoring was for glutaraldehyde, followed by OPA (19% of respondents) 
and HP (17% of respondents).
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With the introduction of additional products approved for use as HLDs by the FDA over the 
last decade, it is important from an occupational health and safety perspective to understand 
the types and use of exposure controls and barriers to using PPE. This survey is the first of 
its kind that evaluates precautionary practices for commonly used HLDs in healthcare 
settings.
Direct skin exposures to HLDs were not uncommon; they were reported by 12% of 
respondents. Gloves and water-resistant gowns should be worn whenever handling HLDs 
and during cleanup of spills to prevent skin contact. Eye/face protection should be worn 
during pouring, draining, and replacing HLDs or whenever splashes are likely. Survey 
findings showed that >4 of every 10 respondents did not always wear water-resistant gowns/
outer garments and that nearly 1 of every 10 did not always wear gloves. Respondents 
reporting skin exposures were 4 times more likely not to wear gloves, and 33% of 
respondents reported not always wearing gloves. Limited use of respiratory protection was 
reported, but respiratory protection is necessary only if airborne exposures exceed 
occupational exposure limits or if air concentrations are unknown, such as during cleanup of 
large spills. ‘Exposure was minimal’ was reported as the most frequent reason for not 
wearing PPE, even though 12% reported direct skin contact with an HLD in the previous 7 
calendar days.
According to OSHA's Hazard Communication Standard (29CFR1910.1200), employers 
must provide training to workers who handle HLDs. Training must include understanding 
the hazards of the chemical(s), safe handling precautions, PPE, emergency procedures (such 
as a spill response), and how to use safety data sheets. Training should occur at the time of 
initial assignment and whenever a new chemical or process change is introduced. Results 
from this survey indicate that some employers are not adhering to this standard; 1 of every 6 
respondents indicated that they had never received training on the safe handling of HLDs.
Potential exposure to HLDs can be reduced through the use of automated systems, where the 
disinfection process occurs in an enclosed unit.18 Exposure to HLDs in automated systems 
generally only occurs during the refilling of reservoirs, during improper handling or disposal 
of containers, as a result of improperly maintained equipment, or during testing of the HLD. 
In our study, 48% of respondents used automated systems, and this statistic was lower for 
dental professionals (14%).
HLD exposure is greatly reduced with the presence of effective LEV. A study in endoscopy 
units found that LEV reduced exposures by >70% in manual disinfection pro-cesses.19 In 
this survey, 42% of survey respondents who used manual disinfection systems reported that 
LEV was absent; of respondents who used automated disinfection systems 15% indicated 
the absence of LEV. The survey did not ascertain whether automated systems required the 
use of LEV or whether the manual systems were covered or uncovered when not in use. 
Greater than 33% of respondents in the study were not sure whether the manual or 
automated disinfection systems were equipped with LEV.
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The results of this survey suggest that use of glutaraldehyde in healthcare settings has 
decreased in favor of alternatives such as OPA and PA. Prior to the 2000s, glutaraldehyde 
use predominately ranged between 84% and 89%.20–22 Findings from this survey indicate 
that glutaraldehyde was used by 59% of respondents, which is slightly elevated compared to 
recent estimates, which ranged from 49% to 55%.23–25 However, these estimates were 
obtained from studies that did not include dental professionals. PA and OPA were less 
commonly used at 16% and 15%, respectively. The majority of survey respondents were 
low-level users of HLDs, with 63% spending <1 hour disinfecting during the previous week 
and 71% disinfecting 10 instruments or fewer during the previous week.
Limitations of the study need to be considered when interpreting the survey results. The 
survey was targeted to professional practice organizations and elicited voluntary 
participation from their members. Because the survey was not a probability sample, the 
conclusions and findings are not representative of the healthcare industry as a whole but are 
limited to healthcare workers who participated. Additionally, the delivery of and response to 
the survey was conducted electronically, limiting respondents to those who have e-mail and 
Internet access. Response rates could not be calculated because the survey invitation 
specified the specific chemical hazards under study; it is unknown who decided not to 
participate because they did not use any of the chemicals and were therefore ineligible 
versus those who used them but decided not to participate for other reasons. Demographic 
information for respondents was not available for participants who did not complete the core 
module. Survey data are self-reported and subject to recall and reporting biases. Information 
on barriers to using LEV (especially on manual systems), automated reprocessors, and spill 
kits were not collected in this study and should be evaluated in future studies.
This survey indicates that the use of recommended PPE, particularly gowns/outer garments, 
is not universal among workers who use HLDs to disinfect medical instruments. Best 
practices for handling HLDs, including wearing protective gloves, water-resistant gowns, 
and eye/face protection to minimize skin and eye exposure, are not always followed. The 
most commonly reported reason for the underutilization of gloves, gowns, and eye/face 
protection suggests a perception that exposures are negligible or so infrequent that they do 
not warrant their use. Lack of training on safe handling practices and lack of employer 
standard procedures suggest that employers may not fully recognize the hazards and 
potential adverse health effects of HLDs.
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Table 1





 Dentist/Dental professional 20
 Respiratory Therapist 13
 Physician 1
 Pharmacist/Pharmacy professional 1
 Other healthcare professional 2















 Dentist office 17
 Outpatient care 11
 Physician office 2
 Offices of other healthcare facilities 2
 Nursing/Residential care 2
 Social assistance/Services 1
 Other 3
Employer ownership type (n=3,932)
 For Profit 44
 Non-profit 43
 City, county, district, state government 9
 Federal government 3
 Other 1
Size of employer (# of employees)b (n=3,935)
 1 1
 2–9 19



















Employer location by population density (n=3,935)
 Large city (>50,000 people) 51
 Small city (<50,000 people) 24
 Suburbs (areas adjacent to cities) 14
 Rural 11





NOTE. HLDs, high-level disinfectants.
a
Number of respondents varied for individual items (eg, number of eligible respondents less number who elected not to answer).
b
Percentages do not total 100 due to rounding.
c
Northeast (CT, ME, MA, NH, NJ, NY, PA, RI, VT); South (AL, AR, DE, DC, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, VA, WV); Midwest 
(IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, WI); West (AK, AZ, CA, CO, HI, ID, MT, NV, NM, OR, UT, WA, WY).

















HLDs usedc (n =4,244)
 Glutaraldehyde 66
 Ortho-phthalaldehyde 20
 Peracetic acid 20
 Hydrogen peroxide 12
 Hydrogen peroxide and peracetic acid 4
 Other HLDs <1
HLD used most often (n =4,231)
 Glutaraldehyde 59
 Peracetic acid 16
 Ortho-phthalaldehyde 15
 Hydrogen peroxide 8
 Hydrogen peroxide and peracetic acid 2
 Other HLDs <1






 6 or 7 7
Total time spent handling HLDsc,d (n=4394)
 <1 h 63
 1–5 h 27
 6–20 h 7
 21–40 h 3
 >40 h 1






Type of disinfection system usedc (n=4195)
 Automated 48
 Manual 64
NOTE. HLD, high-level disinfectant.
a
Number of respondents varied for individual items (eg, number of eligible respondents less number who elected not to answer).
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b
Based on previous 7 calendar days.
c
Percentages may total >100 because respondents could select >1 answer.
d
Includes only time loading or unloading instruments, adding and/or replacing HLD solution, and cleaning processors or trays.
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Table 3
Reasons for Not Always Wearing Personal Protective Equipment When Using High-Level 
Disinfectants
Protective Gloves Nonabsorbent Gown Eye/Face Protection
Reasona n=360, % n= 1,714, % n=1,634, %
An engineering control was being used (–)b 6 5
Exposure was minimal 64 43 53
Not part of our protocol 10 21 14
Not provided by employer 3 7 3
No one else who does this work uses them 3 3 3
Too uncomfortable or difficult to use 2 2 4
Not readily available in work area 5 9 7
Cross contamination to other areas is not a concern 3 3 (–)b
Other 10 6 11
a
Column percentages total >100 because respondents could select >1 answer.
b
Dash (–) indicates this reason was not included in question response options.
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